File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.ejon.2014.11.007
- Scopus: eid_2-s2.0-84930896854
- PMID: 25553718
- WOS: WOS:000357905900001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Use of opioid analgesics or sleeping medication and survival of cancer patients
Title | Use of opioid analgesics or sleeping medication and survival of cancer patients |
---|---|
Authors | |
Keywords | Survival analysis Cancer Opioid analgesics Sleeping medications |
Issue Date | 2015 |
Citation | European Journal of Oncology Nursing, 2015, v. 19, n. 3, p. 199-206 How to Cite? |
Abstract | © 2014 Elsevier Ltd.Purpose of the research: Pain and sleep disturbance have been shown to have a profound influence on the outcomes of cancer treatment. This study sought to determine whether administering opioid analgesics or sleeping medication to cancer patients during their first admission to a hospital is associated with poor prognoses. Methods and sample: We conducted a population-based retrospective cohort study by analyzing data obtained from the National Health Insurance Research Database in Taiwan. The study population comprised cancer patients whose first admission to a hospital for initial cancer treatment was in 2004. Key results: We collected data on 2302 cancer patients. To analyze the effect of opioid analgesic and sleeping medication usage on cancer patient survival, we compared the 3-year survival rates among 4 groups of patients (no use, sleeping medications-only, opioid analgesics-only, both used). The 3-year Kaplan-Meier plots for these 4 groups show that the difference was statistically significant (log rank 48.244, p<0.001). The longevity of cancer patients was the greatest among the no-use group, followed by the sleeping medications-only group, then the opioid analgesics-only group, and finally, the group in which both sleeping medications and opioid analgesics were used. Conclusions: The use of opioid analgesics or sleeping medication was shown to be negatively correlated with the survival rate of cancer patients. |
Persistent Identifier | http://hdl.handle.net/10722/241213 |
ISSN | 2023 Impact Factor: 2.7 2023 SCImago Journal Rankings: 0.801 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chang, Wen Pei | - |
dc.contributor.author | Lin, Chia Chin | - |
dc.date.accessioned | 2017-05-26T03:37:07Z | - |
dc.date.available | 2017-05-26T03:37:07Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | European Journal of Oncology Nursing, 2015, v. 19, n. 3, p. 199-206 | - |
dc.identifier.issn | 1462-3889 | - |
dc.identifier.uri | http://hdl.handle.net/10722/241213 | - |
dc.description.abstract | © 2014 Elsevier Ltd.Purpose of the research: Pain and sleep disturbance have been shown to have a profound influence on the outcomes of cancer treatment. This study sought to determine whether administering opioid analgesics or sleeping medication to cancer patients during their first admission to a hospital is associated with poor prognoses. Methods and sample: We conducted a population-based retrospective cohort study by analyzing data obtained from the National Health Insurance Research Database in Taiwan. The study population comprised cancer patients whose first admission to a hospital for initial cancer treatment was in 2004. Key results: We collected data on 2302 cancer patients. To analyze the effect of opioid analgesic and sleeping medication usage on cancer patient survival, we compared the 3-year survival rates among 4 groups of patients (no use, sleeping medications-only, opioid analgesics-only, both used). The 3-year Kaplan-Meier plots for these 4 groups show that the difference was statistically significant (log rank 48.244, p<0.001). The longevity of cancer patients was the greatest among the no-use group, followed by the sleeping medications-only group, then the opioid analgesics-only group, and finally, the group in which both sleeping medications and opioid analgesics were used. Conclusions: The use of opioid analgesics or sleeping medication was shown to be negatively correlated with the survival rate of cancer patients. | - |
dc.language | eng | - |
dc.relation.ispartof | European Journal of Oncology Nursing | - |
dc.subject | Survival analysis | - |
dc.subject | Cancer | - |
dc.subject | Opioid analgesics | - |
dc.subject | Sleeping medications | - |
dc.title | Use of opioid analgesics or sleeping medication and survival of cancer patients | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.ejon.2014.11.007 | - |
dc.identifier.pmid | 25553718 | - |
dc.identifier.scopus | eid_2-s2.0-84930896854 | - |
dc.identifier.volume | 19 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 199 | - |
dc.identifier.epage | 206 | - |
dc.identifier.eissn | 1532-2122 | - |
dc.identifier.isi | WOS:000357905900001 | - |
dc.identifier.issnl | 1462-3889 | - |